GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of help me understand 503A, I have read the wiki twice — 39 comments in the full submission. View in context.
2.9k
c/compounding·submitted 2 years ago by u/kavya_kravchenko

help me understand 503A, I have read the wiki twice

Pricingbranch of 7 comments

Genuinely asking, not being difficult. Everyone in c/glp1canada repeats that shortage list is important. I believe it, but I have never seen anyone show why, and when I search I get 18 threads of people agreeing with each other. Is there a paper? Is there a measurement? Or is this one of those things that is true…

Read the full submission and all 39 comments →

This branch

7 comments, started 2 years ago
u/tove_ogunleye36 points·2 years ago

Titration speed is a side-effect dial far more than an efficacy dial.

replysharereportpermalink
u/rania_diallo25 points·2 years ago

Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.

replysharereportpermalink
u/ismael_pires17 points·2 years ago

Not convinced. The evidence does not support that reading.

replysharereportpermalink
u/controversial_only25 points·2 years ago

503B compounding is different from 503A, different rules, different legality

replysharereportpermalink
u/elin_ferrari6 points·2 years ago

This is correct. The shortage list does expire and the rules change.

replysharereportpermalink
u/enzo_ferrari15 points·2 years ago

Disagree. What you are describing is consistent with 503B, not with what you concluded.

replysharereportpermalink
u/formulary_fighterappeals18 points·2 years ago

Small correction: the trial was 20 weeks, not 17. Does not change your point but people will quote it.

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →